Phase II trial of capecitabine plus cisplatin as first-line therapy in patients with metastatic nasopharyngeal cancer
Article first published online: 11 NOV 2011
Copyright © 2011 Wiley Periodicals, Inc.
Head & Neck
Volume 34, Issue 9, pages 1225–1230, September 2012
How to Cite
Chua, D. T. T., Yiu, H. H.-Y., Seetalarom, K., Ng, A. W.-Y., Kurnianda, J., Shotelersuk, K., Krishnan, G., Hong, R.-L., Yang, M.-H., Wang, C.-H., Sze, W.-K. and Ng, W.-T. (2012), Phase II trial of capecitabine plus cisplatin as first-line therapy in patients with metastatic nasopharyngeal cancer. Head Neck, 34: 1225–1230. doi: 10.1002/hed.21884
- Issue published online: 10 AUG 2012
- Article first published online: 11 NOV 2011
- Manuscript Accepted: 27 JUN 2011
- Manuscript Revised: 28 MAY 2011
- Manuscript Received: 14 MAR 2011
- Hoffmann–La Roche
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.